Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites
- PMID: 7677958
- PMCID: PMC237386
- DOI: 10.1128/JVI.67.1.489-496.1993
Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites
Abstract
Seven neutralizing murine monoclonal antibodies specific for the glycoprotein H of human cytomegalovirus were produced and used to construct a topological map of two nonoverlapping antigenic sites that are bridged by a third antigenic site. Neutralization assays with 15 laboratory or clinical human cytomegalovirus strains indicated that the monoclonal antibodies recognize three antigenically variable and three conserved epitopes within the three antigenic sites. The variable-domain genes encoding monoclonal antibodies representing each of the three antigenic sites were cloned and sequenced, and molecular models of their binding sites were generated. Conformational differences in the antibody-binding sites suggested a structural basis for experimentally observed differences in gH epitope recognition.
Similar articles
-
Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.J Gen Virol. 1999 Aug;80 ( Pt 8):2183-2191. doi: 10.1099/0022-1317-80-8-2183. J Gen Virol. 1999. PMID: 10466818
-
Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.Virology. 1996 Feb 1;216(1):133-45. doi: 10.1006/viro.1996.0040. Virology. 1996. PMID: 8614980
-
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.J Virol. 1993 Feb;67(2):703-10. doi: 10.1128/JVI.67.2.703-710.1993. J Virol. 1993. PMID: 7678304 Free PMC article.
-
The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.J Virol. 1992 Mar;66(3):1303-11. doi: 10.1128/JVI.66.3.1303-1311.1992. J Virol. 1992. PMID: 1371164 Free PMC article.
-
The molecular basis of antibody-mediated neutralization of West Nile virus.Expert Opin Biol Ther. 2007 Jun;7(6):885-92. doi: 10.1517/14712598.7.6.885. Expert Opin Biol Ther. 2007. PMID: 17555373 Review.
Cited by
-
Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.J Virol. 2020 Aug 31;94(18):e01276-20. doi: 10.1128/JVI.01276-20. Print 2020 Aug 31. J Virol. 2020. PMID: 32641474 Free PMC article.
-
Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope.J Virol. 2004 Aug;78(15):7969-83. doi: 10.1128/JVI.78.15.7969-7983.2004. J Virol. 2004. PMID: 15254169 Free PMC article.
-
Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H.J Virol. 1995 Oct;69(10):6047-53. doi: 10.1128/JVI.69.10.6047-6053.1995. J Virol. 1995. PMID: 7666509 Free PMC article.
-
The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation.J Virol. 1996 Aug;70(8):5557-63. doi: 10.1128/JVI.70.8.5557-5563.1996. J Virol. 1996. PMID: 8764069 Free PMC article.
-
A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection.NPJ Vaccines. 2018 Sep 20;3:38. doi: 10.1038/s41541-018-0074-4. eCollection 2018. NPJ Vaccines. 2018. PMID: 30275984 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources